Diversity and proliferation of metallo-β-lactamases: A clarion call for clinically effective metallo-β-lactamase inhibitors

Applied and Environmental Microbiology

Volumn 84, Issue 18, 2018, Pages

  Somboro, Anou M ^a,b   Sekyere, John Osei ^c   Amoako, Daniel G ^a,b   Essack, Sabiha Y ^a   Bester, Linda A ^b  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

Antibiotic resistance; Gram negative bacteria; Metallo lactamase; Metallo lactamase inhibitors; lactam antibiotics; lactamase

Indexed keywords

AMIDES; AMINO ACIDS; ANTIBIOTICS; ENZYME INHIBITION; METALS;

ANTIBIOTIC RESISTANCE; BACTERIAL INFECTIONS; BACTERIAL RESISTANCE; GRAM-NEGATIVE BACTERIA; LACTAMASES; MULTIDRUG RESISTANTS; STRUCTURAL VARIATIONS; THERAPEUTIC EFFICACY;

BACTERIA;

ANTIBIOTIC RESISTANCE; ANTIBIOTICS; BACTERIUM; CHEMICAL COMPOUND; ENZYME; INHIBITION; INHIBITOR; PUBLIC HEALTH;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; BETA LACTAMASE INHIBITOR;

ANIMAL; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CHEMISTRY; DRUG EFFECT; ENZYMOLOGY; GENETICS; GRAM NEGATIVE BACTERIUM; HUMAN; METABOLISM; MICROBIOLOGY;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BACTERIAL PROTEINS; BETA-LACTAMASE INHIBITORS; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; HUMANS;

EID: 85053462555     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00698-18     Document Type: Short Survey

References (198)

1. Prestinaci F, Pezzotti P, Pantosti A. 2015. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health 109:309-318. https://doi.org/10.1179/2047773215Y.0000000030
2. Osei Sekyere J. 2016. Current state of resistance to antibiotics of last-resort in South Africa: a review from a public health perspective. Front Public Healt 4:209. https://doi.org/10.3389/fpubh.2016.00209
3. Knobler S, Mahmoud A, Lemon S. 2006. A world in motion: the global movement of people, products, pathogens, and power. Inst Med 1:1-33
4. Power E. 2006. Impact of antibiotic restrictions: the pharmaceutical perspective. Clin Microbiol Infect 12:25-34
5. Carlet J, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D. 2012. Ready for a world without antibiotics? The Pensières antibiotic resistance call To Action. Antimicrob Resist Infect Control 1:11
6. Osei Sekyere J, Govinden U, Bester LA, Essack SY. 2016. Colistin and tigecycline resistance in carbapenemase-producing Gram negative bacteria: emerging resistance mechanisms and detection methods. J Appl Microbiol 121:601-617. https://doi.org/10.1111/jam.13169
7. Osei Sekyere J, Asante J. 2018. Emerging mechanisms of antimicrobial resistance in bacteria and fungi: advances in the era of genomics. Future Microbiol 13:1-22. https://doi.org/10.2217/fmb-2017-0172
8. Munita JM, Arias CA. 2016. Mechanisms of antibiotic resistance. Microbiol Spectr 4:2
9. Livermore DM. 2003. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis 36:S11-S23. https://doi.org/10.1086/344654
10. Livermore DM. 1998. Beta-lactamase-mediated resistance and opportunities for its control. J Antimicrob Chemother 41:25-41
11. Osei Sekyere J, Amoako DG. 2017. Carbonyl cyanide m-chlorophenylhydrazine (CCCP) reverses resistance to colistin, but not to carbapenems and tigecycline in multidrug-resistant Enterobacteriaceae. Front Microbiol 8:228. https://doi.org/10.3389/fmicb.2017.00228
12. Bodey GP. 1990. Penicillins, monobactams, and carbapenems. Texas Hear Inst J 17:315
13. Hamed RB, Gomez-Castellanos JR, Henry L, Ducho C, McDonough MA, Schofield CJ. 2013. The enzymes of β-lactam biosynthesis. Nat Prod Rep 30:21-107. https://doi.org/10.1039/C2NP20065A
14. Queenan AM, Bush K. 2007. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev 20:440-458. https://doi.org/10.1128/CMR.00001-07
15. Ambler RP. 1980. The structure of beta-lactamases. Philos Trans R Soc Lond B 289:321. https://doi.org/10.1098/rstb.1980.0049
16. Bush K, Jacoby GA. 2010. Updated functional classification of betalactamases. Antimicrob Agents Chemother 54:969-976. https://doi.org/10.1128/AAC.01009-09
17. Bush K. 2013. Carbapenemases: partners in crime. J Glob Antimicrob Resist 1:7-16. https://doi.org/10.1016/j.jgar.2013.01.005
18. Bush K, Bradford PA. 2016. Beta-lactams and beta-lactamase inhibitors: an overview. Cold Spring Harb Perspect Med 6:a025247. https://doi.org/10.1101/cshperspect.a025247
19. Bebrone C. 2007. Metallo-β-lactamases (classification, activity, genetic organization, structure, zinc coordination) and their superfamily. Biochem Pharmacol 74:1686-1701. https://doi.org/10.1016/j.bcp.2007.05.021
20. Kelly AM, Mathema B, Larson EL. 2017. Carbapenem-resistant Enterobacteriaceae in the community: a scoping review. Int J Antimicrob Agents 50:127-134. https://doi.org/10.1016/j.ijantimicag.2017.03.012
21. Potter RF, D'Souza AW, Dantas G. 2016. The rapid spread of carbapenem-resistant Enterobacteriaceae. Drug Resist Updat 29: 30-46. https://doi.org/10.1016/j.drup.2016.09.002
22. Gupta N, Limbago BM, Patel JB, Kallen AJ. 2011. Carbapenem-resistant enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 53: 60-67. https://doi.org/10.1093/cid/cir202
23. Falagas ME, Tansarli GS, Karageorgopoulos DE, Vardakas KZ. 2014. Deaths attributable to carbapenem-resistant Enterobacteriaceae infections. Emerg Infect Dis 20:1170-1175. https://doi.org/10.3201/eid2007.121004
24. Van Duin D, Kaye KS, Neuner EA, Bonomo RA. 2013. Carbapenemresistant Enterobacteriaceae: a review of treatment and outcomes. Diagn Microbiol Infect Dis 75:115-120. https://doi.org/10.1016/j.diagmicrobio.2012.11.009
25. Kim UJ, Kim HK, An JH, Cho SK, Park K-H, Jang H-C. 2014. Update on the epidemiology, treatment, and outcomes of carbapenem-resistant Acinetobacter infections. Chonnam Med J 50:37-44. https://doi.org/10.4068/cmj.2014.50.2.37
26. Wang X, Chen G, Wu X, Wang L, Cai J, Chan EW, Chen S, Zhang R. 2015. Increased prevalence of carbapenem resistant Enterobacteriaceae in hospital setting due to cross-species transmission of the blaNDM-1 element and clonal spread of progenitor resistant strains. Front Microbiol 6:595. https://doi.org/10.3389/fmicb.2015.00595
27. Pittet D, Allegranzi B, Storr J, Nejad SB, Dziekan G, Leotsakos A, Donaldson L. 2008. Infection control as a major World Health Organization priority for developing countries. J Hosp Infect 68:285-292. https://doi.org/10.1016/j.jhin.2007.12.013
28. World Health Organization. 2017. Global priority list of antibioticresistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organization, Geneva Switzerland
29. Walsh TR, Toleman MA, Poirel L, Nordmann P. 2005. metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev 18:306-325. https://doi.org/10.1128/CMR.18.2.306-325.2005
30. Lim HM, Pene JJ, Shaw RW. 1988. Cloning, nucleotide sequence, and expression of the Bacillus cereus 5/B/6 β-lactamase II structural gene. J Bacteriol 170:2873-2878. https://doi.org/10.1128/jb.170.6.2873-2878.1988
31. Walsh TR, Hall L, Assinder SJ, Nichols WW, Cartwright SJ, MacGowan AP, Bennett PM. 1994. Sequence analysis of the L1 metallo-β-lactamase from Xanthomonas maltophilia. Biochim Biophys Acta 1218:199-201. https://doi.org/10.1016/0167-4781(94)90011-6
32. Sabath LD, Abraham EP. 1966. Zinc as a cofactor for cephalosporinase from Bacillus cereus 569. Biochem J 98:11C. https://doi.org/10.1042/ bj0980011C
33. Kuwabara S, Abraham EP. 1967. Some properties of two extracellular beta-lactamases from Bacillus cereus 569/H. Biochem J 103:27C. https://doi.org/10.1042/bj1030027C
34. Cornaglia G, Giamarellou H, Rossolini GM. 2011. Metallo-betalactamases: a last frontier for beta-lactams? Lancet Infect Dis 11: 381-393. https://doi.org/10.1016/S1473-3099(11)70056-1
35. Laraki N, Galleni M, Thamm I, Riccio ML, Amicosante G, Frère JM, Rossolini GM. 1999. Structure of In31, a bla(IMP)-containing Pseudomonas aeruginosa integron phyletically related to In5, which carries an unusual array of gene cassettes. Antimicrob Agents Chemother 43: 890-901
36. Bennett PM. 2008. Plasmid encoded antibiotic resistance: acquisition and transfer of antibiotic resistance genes in bacteria. Br J Pharmacol 153:S347-S357. https://doi.org/10.1038/sj.bjp.0707607
37. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. 2009 Characterization of a new metallo-beta-lactamase gene, bla NDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046-5054. https://doi.org/10.1128/AAC.00774-09
38. Karsisiotis AI, Damblon CF, Roberts GCK. 2014. A variety of roles for versatile zinc in metallo-β-lactamases. Metallomics 6:1181-1197. https://doi.org/10.1039/C4MT00066H
39. Galleni M, Lamotte-Brasseur J, Rossolini GM, Spencer J, Dideberg O, Frère JM, Amicosante G, Franceschini N, Bush K, Concha NO, Herzberg O, Livermore DM, Rasmussen BA, Rodrigues J, Saavedra MJ, Sutton B, Fabiane SM, Toney JH. 2001. Standard numbering scheme for class B β-lactamases. Antimicrob Agents Chemother 45:660-663. https://doi.org/10.1128/AAC.45.3.660-663.2001
40. Mojica MF, Bonomo RA, Fast W. 2016. B1-metallo-β-lactamases: where do we stand? Curr Drug Targets 17:1029-1050. https://doi.org/10.2174/1389450116666151001105622
41. Jia B, Raphenya AR, Alcock B, Waglechner N, Guo P, Tsang KK, Lago BA, Dave BM, Pereira S, Sharma AN. 2017. CARD 2017: expansion and model-centric curation of the comprehensive antibiotic resistance database. Nucleic Acids Res 45:D566-D573. https://doi.org/10.1093/nar/ gkw1004
42. Naas T, Oueslati S, Bonnin RA, Dabos ML, Zavala A, Dortet L, Retailleau P, Iorga BI. 2017. Beta-lactamase database (BLDB)-structure and function. J Enzyme Inhib Med Chem 32:917-919. https://doi.org/10.1080/14756366.2017.1344235
43. Hall BG, Salipante SJ, Barlow M. 2004. Independent origins of subgroup Bl+B2 and subgroup B3 metallo-β-lactamases. J Mol Evol 59:133-141. https://doi.org/10.1007/s00239-003-2572-9
44. Hall BG, Salipante SJ, Barlow M. 2003. The metallo-β-lactamases fall into two distinct phylogenetic groups. J Mol Evol 57:249-254. https://doi.org/10.1007/s00239-003-2471-0
45. Asnicar F, Weingart G, Tickle TL, Huttenhower C, Segata N. 2015. Compact graphical representation of phylogenetic data and metadata with GraPhlAn. Peer J 3:e1029. https://doi.org/10.7717/peerj.1029
46. Berglund F, Marathe NP, österlund T, Bengtsson-Palme J, Kotsakis S, Flach C-F, Larsson DGJ, Kristiansson E. 2017. Identification of 76 novel B1 metallo-β-lactamases through large-scale screening of genomic and metagenomic data. Microbiome 5:134. https://doi.org/10.1186/s40168-017-0353-8
47. McGeary RP, Tan DT, Schenk G. 2017. Progress toward inhibitors of metallo-β-lactamases. Future Med Chem 9:673-691. https://doi.org/10.4155/fmc-2017-0007
48. Tehrani KHME, Martin NI. 2017. Thiol-containing metallo-β-lactamase inhibitors resensitize resistant Gram-negative bacteria to meropenem. ACS Infect Dis 3:711-717. https://doi.org/10.1021/acsinfecdis.7b00094
49. Toney JH, Fitzgerald PM, Grover-Sharma N, Olson SH, May WJ, Sundelof JG, Vanderwall DE, Cleary K a, Grant SK, Wu JK, Kozarich JW, Pompliano DL, Hammond GG. 1998. Antibiotic sensitization using biphenyl tetrazoles as potent inhibitors of Bacteroides fragilis metallo-beta-lactamase. Chem Biol 5:185-196. https://doi.org/10.1016/S1074-5521(98)90632-9
50. Walter MW, Valladares MH, Adlington RM, Amicosante G, Baldwin JE, Frère J-M, Galleni M, Rossolini GM, Schofield CJ. 1999. Hydroxamate inhibitors of Aeromonas hydrophila AE036 metallo-B-lactamase. Bioorg Chem 27:35-40. https://doi.org/10.1006/bioo.1998.1111
51. Fitzgerald PMD, Wu JK, Toney JH. 1998. Unanticipated inhibition of the metallo-β-lactamase from Bacteroides fragilis by 4-morpholineethanesulfonic acid (MES): a crystallographic study at 1.85-Å resolution. Biochemistry 37: 6791-6800. https://doi.org/10.1021/bi9730339
52. Buynak JD, Chen H, Vogeti L, Gadhachanda VR, Buchanan CA, Palzkill T, Shaw RW, Spencer J, Walsh TR. 2004. Penicillin-derived inhibitors that simultaneously target both metallo-and serine-β-lactamases. Bioorg Med Chem Lett 14:1299-1304. https://doi.org/10.1016/j.bmcl.2003.12.037
53. Mohamed MS, Hussein WM, McGeary RP, Vella P, Schenk G, Abd El-hameed RH. 2011. Synthesis and kinetic testing of new inhibitors for a metallo-β-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa. Eur J Med Chem 46:6075-6082. https://doi.org/10.1016/j.ejmech.2011.10.030
54. Horsfall LE, Garau G, Liénard BMR, Dideberg O, Schofield CJ, Frère JM, Galleni M. 2007. Competitive inhibitors of the CphA metallo-β-lactamase from Aeromonas hydrophila. Antimicrob Agents Chemother 51:2136-2142. https://doi.org/10.1128/AAC.00866-06
55. Bounaga S, Galleni M, Laws AP, Page MI. 2001. Cysteinyl peptide inhibitors of Bacillus cereus zinc β-lactamase. Bioorg Med Chem 9:503-510. https://doi.org/10.1016/S0968-0896(00)00257-1
56. Payne DJ, Hueso-Rodríguez JA, Boyd H, Concha NO, Janson CA, Gilpin M, Bateson JH, Cheever C, Niconovich NL, Pearson S, Rittenhouse S, Tew D, Díez E, Pérez P, De la Fuente J, Rees M, Rivera-Sagredo A. 2002. Identification of a series of tricyclic natural products as potent broad-spectrum inhibitors of metallo-β-lactamases. Antimicrob Agents Chemother 46: 1880-1886. https://doi.org/10.1128/AAC.46.6.1880-1886.2002
57. Shaw RW, Cottenoir M. March 2010. Inhibiton of metallo-betalactamase by double-stranded DNA. US patent 8,143,389
58. Siemann S, Brewer D, Clarke AJ, Dmitrienko GI, Lajoie G, Viswanatha T. 2002 IMP-1 metallo-β-lactamase: effect of chelators and assessment of metal requirement by electrospray mass spectrometry. Biochim Biophys Acta 1571:190-200. https://doi.org/10.1016/S0304-4165(02)00258-1
59. Greenlee ML, Laub JB, Balkovec JM, Hammond ML, Hammond GG, Pompliano DL, Epstein-Toney JH. 1999. Synthesis and SAR of thioester and thiol inhibitors of IMP-1 metallo-β-lactamase. Bioorg Med Chem Lett 9:2549-2554. https://doi.org/10.1016/S0960-894X(99)00425-4
60. Goto M, Takahashi T, Yamashita F, Koreeda A, Mori H, Ohta M, Arakawa Y. 1997. Inhibition of the metallo-beta-lactamase produced from Serratia marcescens by thiol compounds. Biol Pharm Bull 20:1136-1140. https://doi.org/10.1248/bpb.20.1136
61. Payne DJ, Bateson JH, Gasson BC, Proctor D, Khushi T, Farmer TH, Tolson DA, Bell D, Skett PW, Marshall AC, Reid R, Ghosez L, Combret Y, Marchand-Brynaert J. 1997. Inhibition of metallo-beta-lactamases by a series of mercaptoacetic acid thiol ester derivatives. Antimicrob Agents Chemother 41:135-140
62. Mollard C, Moali C, Papamicael C, Damblon C, Vessilier S, Amicosante G, Schofield CJ, Galleni M, Frère JM, Roberts GCK. 2001. Thiomandelic acid, a broad spectrum inhibitor of zinc β-lactam. Kinetic and spectroscopic studiesases. J Biol Chem 276:45015-45023
63. Liénard BMR, Garau G, Horsfall L, Karsisiotis AI, Damblon C, Lassaux P, Papamicael C, Roberts GCK, Galleni M, Dideberg O, Frere J-M, Schofield CJ. 2008. Structural basis for the broad-spectrum inhibition of metallobeta-lactamases by thiols. Org Biomol Chem 6:2282-2294. https://doi.org/10.1039/b802311e
64. Heinz U, Bauer R, Wommer S, Meyer-Klaucke W, Papamichaels C, Bateson J, Adolph HW. 2003. Coordination geometries of metal ions in D-or L-captopril-inhibited metallo-β-lactamases. J Biol Chem 278: 20659-20666. https://doi.org/10.1074/jbc.M212581200
65. Brem J, van Berkel SS, Zollman D, Lee SY, Gileadi O, McHugh PJ, Walsh TR, McDonough MA, Schofield CJ. 2016. Structural basis of metallo-β-lactamase inhibition by captopril stereoisomers. Antimicrob Agents Chemother 60:142-150. https://doi.org/10.1128/AAC.01335-15
66. Cui-Gai Bai, Yin-Tong Xu, Ning-Ning Li, Jing-Han Wang, Cheng Yang, Yue Chen, Hong-Gang Zhou. 2015. Cysteine and its derivatives as New Delhi metallo-beta-lactamase-1 inhibitors. Curr Enzym Inhib 11:46-57. https://doi.org/10.2174/1573408011666150408223245
67. Ishii Y, Eto M, Mano Y, Tateda K, Yamaguchi K. 2010. In vitro potentiation of carbapenems with ME1071, a novel metallo-beta-lactamase inhibitor, against metallo-beta-lactamase-producing Pseudomonas aeruginosa clinical isolates. Antimicrob Agents Chemother 54: 3625-3629. https://doi.org/10.1128/AAC.01397-09
68. Yamada K, Yanagihara K, Kaku N, Harada Y, Migiyama Y, Nagaoka K, Morinaga Y, Nakamura S, Imamura Y, Miyazaki T, Izumikawa K, Kakeya H, Hasegawa H, Yasuoka A, Kohno S. 2013. In vivo efficacy of biapenem with ME1071, a novel metallo-beta-lactamase (MBL) inhibitor, in a murine model mimicking ventilator-associated pneumonia caused by MBL-producing Pseudomonas aeruginosa. Int J Antimicrob Agents 42: 238-243. https://doi.org/10.1016/j.ijantimicag.2013.05.016
69. Hiraiwa Y, Saito J, Watanabe T, Yamada M, Morinaka A, Fukushima T, Kudo T. 2014. X-ray crystallographic analysis of IMP-1 metallo-β-lactamase complexed with a 3-aminophthalic acid derivative, structurebased drug design, and synthesis of 3,6-disubstituted phthalic acid derivative inhibitors. Bioorg Med Chem Lett 24:4891-4894. https://doi.org/10.1016/j.bmcl.2014.08.039
70. Hiraiwa Y, Morinaka A, Fukushima T, Kudo T. 2013. Metallo-β-lactamase inhibitory activity of 3-alkyloxy and 3-amino phthalic acid derivatives and their combination effect with carbapenem. Bioorgc Med Chem 21:5841-5850. https://doi.org/10.1016/j.bmc.2013.07.006
71. Materon IC, Queenan AM, Koehler TM, Bush K, Palzkill T. 2003. Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis. Antimicrob Agents Chemother 47:2040-2042. https://doi.org/10.1128/AAC.47.6.2040-2042.2003
72. Kim S-K, Demuth M, Schlesinger SR, Kim SJ, Urbanczyk J, Shaw RW, Shin H. 2016. Inhibition of Bacillus anthracis metallo-β-lactamase by compounds with hydroxamic acid functionality. J Enzyme Inhib Med Chem 31:132-137
73. Chen P, Horton L, Mikulski R. 2012. 2-Substituted 4, 5-dihydrothiazole-4-carboxylic acids are novel inhibitors of metallo-β-lactamases. Bioorg Med Chem Lett 22:6229-6232. https://doi.org/10.1016/j.bmcl.2012.08.012
74. Brem J, Cain R, Cahill S, McDonough MA, Clifton IJ, Jiménez-Castellanos J-C, Avison MB, Spencer J, Fishwick CWG, Schofield CJ. 2016. Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates. Nat Commun 7:12406. https:// doi.org/10.1038/ncomms12406
75. Hussein WM, Fatahala SS, Mohamed ZM, Mcgeary RP, Schenk G, Ollis DL, Mohamed MS. 2012. Synthesis and kinetic testing of tetrahydropyrimidine-2-thione and pyrrole derivatives as inhibitors of the metallo-beta-lactamase from Klebsiella pneumonia and Pseudomonas aeruginosa. Chem Biol Drug Des 80:500-515. https://doi.org/10.1111/j.1747-0285.2012.01440.x
76. Denny BJ, Lambert PA, West PWJ. 2002. The flavonoid galangin inhibits the L1 metallo-beta-lactamase from Stenotrophomonas maltophilia. FEMS Microbiol Lett 208:21-24. https://doi.org/10.1016/ S0378-1097(01)00580-8,10.1111/j.1574-6968.2002.tb11054.x
77. Gan M, Liu Y, Bai Y, Guan Y, Li L, Gao R, He W, You X, Li Y, Yu L, Xiao C. 2013. Polyketides with New Delhi metallo-β-lactamase 1 inhibitory activity from Penicillium sp. J Nat Prod 76:1535-1540. https://doi.org/10.1021/np4000944
78. King AM, Reid-Yu SA, Wang W, King DT, De Pascale G, Strynadka NC, Walsh TR, Coombes BK, Wright GD. 2014. Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance. Nature 510:503-506. https://doi.org/10.1038/nature13445
79. Nagano R, Adachi Y, Imamura H, Yamada K, Hashizume T, Morishima H. 1999 Carbapenem derivatives as potential inhibitors of various β-lactamases, including class B metallo-β-lactamases. Antimicrob Agents Chemother 43:2497-2503
80. Beharry Z, Chen H, Gadhachanda VR, Buynak JD, Palzkill T. 2004. Evaluation of penicillin-based inhibitors of the class A and B β-lactamases from Bacillus anthracis. Biochem Biophys Res Commun 313:541-545. https://doi.org/10.1016/j.bbrc.2003.11.158
81. Tsang WY, Dhanda A, Schofield CJ, Frère JM, Galleni M, Page MI. 2004. The inhibition of metallo-β-lactamase by thioxo-cephalosporin derivatives. Bioorg Med Chem Lett 14:1737-1739. https://doi.org/10.1016/j.bmcl.2004.01.047
82. Ganta SR, Perumal S, Pagadala SRR, Samuelsen Ø, Spencer J, Pratt RF, Buynak JD. 2009. Approaches to the simultaneous inactivation of metallo-and serine-β-lactamases. Bioorg Med Chem Lett 19: 1618-1622. https://doi.org/10.1016/j.bmcl.2009.02.018
83. Johnson JW, Gretes M, Goodfellow VJ, Marrone L, Heynen ML, Strynadka NCJ, Dmitrienko GI. 2010. Cyclobutanone analogues of β-lactams revisited: Insights into conformational requirements for inhibition of serine-and metallo-β-lactamases. J Am Chem Soc 132: 2558-2560. https://doi.org/10.1021/ja9086374
84. Docquier J-D, Lamotte-Brasseur J, Galleni M, Amicosante G, Frère J-M, Rossolini GM. 2003. On functional and structural heterogeneity of VIM-type metallo-beta-lactamases. J Antimicrob Chemother 51: 257-266. https://doi.org/10.1093/jac/dkg067
85. Yoshizumi A, Ishii Y, Livermore DM, Woodford N, Kimura S, Saga T, Harada S, Yamaguchi K, Tateda K. 2013. Efficacies of calcium-EDTA in combination with imipenem in a murine model of sepsis caused by Escherichia coli with NDM-1 Beta-lactamase. J Infect Chemother 19: 992-995. https://doi.org/10.1007/s10156-012-0528-y
86. Roll DM, Yang Y, Wildey MJ, Bush K, Lee MD. 2010. Inhibition of metallo-beta-lactamases by pyridine monothiocarboxylic acid analogs. J Antibiot (Tokyo) 63:255-257. https://doi.org/10.1038/ja.2010.20
87. Somboro AM, Tiwari D, Bester LA, Parboosing R, Chonco L, Kruger HG, Arvidsson PI, Govender T, Naicker T, Essack SY. 2015. NOTA: a potent metallo-β-lactamase inhibitor. J Antimicrob Chemother 70:1594-1596. https://doi.org/10.1093/jac/dku538
88. Azumah R, Dutta J, Somboro AM, Ramtahal M, Chonco L, Parboosing R, Bester LA, Kruger HG, Naicker T, Essack SY, Govender T. 2016. In vitro evaluation of metal chelators as potential metallo-β-lactamase inhibitors. J Appl Microbiol 120:860-867. https://doi.org/10.1111/jam.13085
89. Carfi A, Pares S, Duee E, Galleni M, Duez C, Frère J-M, Dideberg O. 1995. The 3-D structure of a zinc metallo-beta-lactamase from Bacillus cereus reveals a new type of protein fold. EMBO J 14:4914
90. Matagne A, Dubus A, Galleni M, Frère J-M. 1999. The β-lactamase cycle: a tale of selective pressure and bacterial ingenuity. Nat Prod Rep 16:1-19. https://doi.org/10.1039/a705983c
91. Yang Y, Rasmussen BA, Bush K. 1992. Biochemical characterization of the metallo-beta-lactamase CcrA from Bacteroides fragilis TAL3636. Antimicrob Agents Chemother 36:1155-1157. https://doi.org/10.1128/ AAC.36.5.1155
92. Rasmussen BA, Gluzman Y, Tally FP. 1991. Escherichia coli chromosomal mutations that permit direct cloning of the Bacteroides fragilis metallo-β-lactamase gene, ccrA. Mol Microbiol 5:1211-1219. https://doi.org/10.1111/j.1365-2958.1991.tb01895.x
93. Osano E, Arakawa Y, Wacharotayankun R, Ohta M, Horii T, Ito H, Yoshimura F, Kato N. 1994. Molecular characterization of an enterobacterial metallo beta-lactamase found in a clinical isolate of Serratia marcescens that shows imipenem resistance. Antimicrob Agents Chemother 38:71-78. https://doi.org/10.1128/AAC.38.1.71
94. Oelschlaeger P, Ai N, DuPrez KT, Welsh WJ, Toney JH. 2010. Evolving carbapenemases: can medicinal chemists advance one step ahead of the coming storm? J Med Chem 53:3013-3027. https://doi.org/10.1021/ jm9012938
95. Vessillier S, Docquier J-D, Rival S, Frere J-M, Galleni M, Amicosante G, Rossolini GM, Franceschini N. 2002. Overproduction and biochemical characterization of the Chryseobacterium meningosepticum BlaB metallo-β-lactamase. Antimicrob Agents Chemother 46:1921-1927. https://doi.org/10.1128/AAC.46.6.1921-1927.2002
96. Rossolini G, Franceschini N, Riccio M, Mercuri P, Perilli M, Galleni M, Frere J, Amicosante G. 1998. Characterization and sequence of the Chryseobacterium (Flavobacterium) meningosepticum carbapenemase: a new molecular class B β-lactamase showing a broad substrate profile. Biochem J 332:145-152. https://doi.org/10.1042/bj3320145
97. Yum JH, Lee EY, Hur S-H, Jeong SH, Lee H, Yong D, Chong Y, Lee E-W, Nordmann P, Lee K. 2010. Genetic diversity of chromosomal metallo-β-lactamase genes in clinical isolates of Elizabethkingia meningoseptica from Korea. J Microbiol 48:358-364. https://doi.org/10.1007/s12275-010-9308-5
98. Lauretti L, Riccio ML, Mazzariol A, Cornaglia G, Amicosante G, Fontana R, Rossolini GM. 1999. Cloning and characterization of bla VIM, a new integron-borne metallo-β-lactamase gene from a Pseudomonas aeruginosa clinical isolate. Antimicrob Agents Chemother 43: 1584-1590
99. Bellais S, Léotard S, Poirel L, Naas T, Nordmann P. 1999. Molecular characterization of a carbapenem-hydrolyzing β-lactamase from Chryseobacterium (Flavobacterium) indologenes. FEMS Microbiol Lett 171:127-132
100. Bellais S, Girlich D, Karim A, Nordmann P. 2002. EBR-1, a novel Ambler subclass B1 β-lactamase from Empedobacter brevis. Antimicrob Agents Chemother 46:3223-3227. https://doi.org/10.1128/ AAC.46.10.3223-3227.2002
101. Toleman MA, Simm AM, Murphy TA, Gales AC, Biedenbach DJ, Jones RN, Walsh TR. 2002. Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother 50: 673-679. https://doi.org/10.1093/jac/dkf210
102. Gales AC, Menezes LC, Silbert S, Sader HS. 2003. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-β-lactamase. J Antimicrob Chemother 52:699-702. https://doi.org/10.1093/jac/dkg416
103. Castanheira M, Toleman MA, Jones RN, Schmidt FJ, Walsh TR. 2004. Molecular characterization of a β-lactamase gene, blaGIM-1, encoding a new subclass of metallo-β-lactamase. Antimicrob Agents Chemother 48:4654-4661. https://doi.org/10.1128/AAC.48.12.4654-4661.2004
104. Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier J-D, Rossolini GM, Chong Y. 2005. Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother 49:4485-4491. https://doi.org/10.1128/AAC.49.11.4485-4491.2005
105. Poirel L, Héritier C, Nordmann P. 2005. Genetic and biochemical characterization of the chromosome-encoded class B β-lactamases from Shewanella livingstonensis (SLB-1) and Shewanella frigidimarina (SFB-1). J Antimicrob Chemother 55:680-685. https://doi.org/10.1093/jac/ dki065
106. Gudeta DD, Bortolaia V, Amos G, Wellington EMH, Brandt KK, Poirel L, Nielsen JB, Westh H, Guardabassi L. 2016. The soil microbiota harbors a diversity of carbapenem-hydrolyzing β-lactamases of potential clinical relevance. Antimicrob Agents Chemother 60:151-160. https://doi.org/10.1128/AAC.01424-15
107. Naas T, Bellais S, Nordmann P. 2003. Molecular and biochemical characterization of a carbapenem-hydrolysing β-lactamase from Flavobacterium johnsoniae. J Antimicrob Chemother 51:267-273. https://doi.org/10.1093/jac/dkg069
108. Bellais S, Naas T, Nordmann P. 2002. Genetic and biochemical characterization of CGB-1, an Ambler class B carbapenem-hydrolyzing β-lactamase from Chryseobacterium gleum. Antimicrob Agents Chemother 46: 2791-2796. https://doi.org/10.1128/AAC.46.9.2791-2796.2002
109. Mammeri H, Bellais S, Nordmann P. 2002. Chromosome-encoded β-lactamases TUS-1 and MUS-1 from Myroides odoratus and Myroides odoratimimus (formerly Flavobacterium odoratum), new members of the lineage of molecular subclass B1 metalloenzymes. Antimicrob Agents Chemother 46:3561-3567. https://doi.org/10.1128/AAC.46.11.3561-3567.2002
110. Al-Bayssari C, Gupta SK, Dabboussi F, Hamze M, Rolain J-M. 2015. MUS-2, a novel variant of the chromosome-encoded β-lactamase MUS-1, from Myroides odoratimimus. New Microbes New Infect 7:67-71. https://doi.org/10.1016/j.nmni.2015.06.007
111. Sekiguchi J, Morita K, Kitao T, Watanabe N, Okazaki M, Miyoshi-Akiyama T, Kanamori M, Kirikae T. 2008. KHM-1, a novel plasmid-mediated metallo-β-lactamase from a Citrobacter freundii clinical isolate. Antimi-crob Agents Chemother 52:4194-4197. https://doi.org/10.1128/AAC.01337-07
112. Poirel L, Rodríguez-Martínez J-M, Al Naiemi N, Debets-Ossenkopp YJ, Nordmann P. 2010. Characterization of DIM-1, an integron-encoded metallo-β-lactamase from a Pseudomonas stutzeri clinical isolate in the Netherlands. Antimicrob Agents Chemother 54:2420-2424. https://doi.org/10.1128/AAC.01456-09
113. Nordmann P, Poirel L, Toleman MA, Walsh TR. 2011. Does broadspectrum β-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Chemother 66:689-692. https://doi.org/10.1093/jac/dkq520
114. Hornsey M, Phee L, Wareham DW. 2011. A novel variant, NDM-5, of the New Delhi metallo-β-lactamase in a multidrug-resistant Escherichia coli ST648 isolate recovered from a patient in the United Kingdom. Antimicrob Agents Chemother 55:5952-5954. https://doi.org/10.1128/AAC.05108-11
115. Nordmann P, Poirel L, Walsh TR, Livermore DM. 2011. The emerging NDM carbapenemases. Trends Microbiol 19:588-595. https://doi.org/10.1016/j.tim.2011.09.005
116. Pfennigwerth N, Lange F, Belmar Campos C, Hentschke M, Gatermann SG, Kaase M. 2017. Genetic and biochemical characterization of HMB-1, a novel subclass B1 metallo-β-lactamase found in a Pseudomonas aeruginosa clinical isolate. J Antimicrob Chemother 72:1068-1073. https://doi.org/10.1093/jac/dkw554
117. Pollini S, Maradei S, Pecile P, Olivo G, Luzzaro F, Docquier J-D, Rossolini GM. 2013. FIM-1, a new acquired metallo-β-lactamase from a Pseudomonas aeruginosa clinical isolate from Italy. Antimicrob Agents Chemother 57:410-416. https://doi.org/10.1128/AAC.01953-12
118. El Salabi A, Borra PS, Toleman MA, Samuelsen Ø, Walsh TR. 2012. Genetic and biochemical characterization of a novel metallo-β-lactamase, TMB-1, from an Achromobacter xylosoxidans strain isolated in Tripoli, Libya. Antimicrob Agents Chemother 56:2241-2245. https:// doi.org/10.1128/AAC.05640-11
119. Suzuki S, Matsui M, Suzuki M, Sugita A, Kosuge Y, Kodama N, Ichise Y, Shibayama K. 2013. Detection of Tripoli metallo-β-lactamase 2 (TMB-2), a variant of bla TMB-1, in clinical isolates of Acinetobacter spp. in Japan. J Antimicrob Chemother 68:1441-1442. https://doi.org/10.1093/jac/ dkt031
120. Gudeta DD, Bortolaia V, Pollini S, Docquier J-D, Rossolini GM, Amos GCA, Wellington EMH, Guardabassi L. 2016. Expanding the repertoire of carbapenem-hydrolyzing metallo-β-lactamases by functional metagenomic analysis of soil microbiota. Front Microbiol 7:1985. https://doi.org/10.3389/fmicb.2016.01985
121. Lin H-TV, Massam-Wu T, Lin C-P, Wang Y-JA, Shen Y-C, Lu W-J, Hsu P-H, Chen Y-H, Borges-Walmsley MI, Walmsley AR. 2017. The Vibrio cholerae var regulon encodes a metallo-β-lactamase and an antibiotic efflux pump, which are regulated by VarR, a LysR-type transcription factor. PLoS One 12:e0184255. https://doi.org/10.1371/journal.pone.0184255
122. Massidda O, Rossolini GM, Satta G. 1991. The Aeromonas hydrophila cphA gene: molecular heterogeneity among class B metallo-betalactamases. J Bacteriol 173:4611-4617. https://doi.org/10.1128/jb.173.15.4611-4617.1991
123. Segatore B, Massidda O, Satta G, Setacci D, Amicosante G. 1993. High specificity of cphA-encoded metallo-beta-lactamase from Aeromonas hydrophila AE036 for carbapenems and its contribution to beta-lactam resistance. Antimicrob Agents Chemother 37:1324-1328. https://doi.org/10.1128/AAC.37.6.1324
124. Walsh TR, Gamblin S, Emery DC, MacGowan AP, Bennett PM. 1996. Enzyme kinetics and biochemical analysis of ImiS, the metallo-β-lactamase from Aeromonas sobria 163a. J Antimicrob Chemother 37: 423-431. https://doi.org/10.1093/jac/37.3.423
125. Walsh TR, Neville WA, Haran MH, Tolson D, Payne DJ, Bateson JH, MacGowan AP, Bennett PM. 1998. Nucleotide and amino acid sequences of the metallo-β-lactamase, ImiS, from Aeromonas veronii bv. sobria. Antimicrob Agents Chemother 42:436-439
126. Niumsup P, Simm AM, Nurmahomed K, Walsh TR, Bennett PM, Avison MB. 2003. Genetic linkage of the penicillinase gene, amp, and blrAB, encoding the regulator of β-lactamase expression in Aeromonas spp. J Antimicrob Chemother 51:1351-1358. https://doi.org/10.1093/jac/dkg247
127. Saavedra MJ, Peixe L, Sousa JC, Henriques I, Alves A, Correia A. 2003. Sfh-I, a subclass B2 metallo-β-lactamase from a Serratia fonticola environmental isolate. Antimicrob Agents Chemother 47: 2330-2333. https://doi.org/10.1128/AAC.47.7.2330-2333.2003
128. Ullah JH, Walsh TR, Taylor IA, Emery DC, Verma CS, Gamblin SJ, Spencer J. 1998. The crystal structure of the L1 metallo-β-lactamase from Stenotrophomonas maltophilia at 1.7 Å resolution. J Mol Biol 284: 125-136. https://doi.org/10.1006/jmbi.1998.2148
129. Yang Z, Liu W, Cui Q, Niu WK, Li H, Zhao XN, Wei X, Wang XS, Huang SM, Dong DR. 2014. Prevalence and detection of Stenotrophomonas maltophilia carrying metallo-β-lactamase blaL1 in Beijing, China. Front Microbiol 5:692. https://doi.org/10.3389/fmicb.2014.00692
130. Saino Y, Kobayashi F, Inoue M, Mitsuhashi S. 1982. Purification and properties of inducible penicillin beta-lactamase isolated from Pseudomonas maltophilia. Antimicrob Agents Chemother 22:564-570. https://doi.org/10.1128/AAC.22.4.564
131. Boschi L, Mercuri PS, Riccio ML, Amicosante G, Galleni M, Frère J-M, Rossolini GM. 2000. The Legionella (Fluoribacter) gormanii metallo-β-lactamase: a new member of the highly divergent lineage of molecularsubclass B3 β-lactamases. Antimicrob Agents Chemother 44: 1538-1543. https://doi.org/10.1128/AAC.44.6.1538-1543.2000
132. Bellais S, Aubert D, Naas T, Nordmann P. 2000. Molecular and biochemical heterogeneity of class B carbapenem-hydrolyzing β-lactamases in Chryseobacterium meningosepticum. Antimicrob Agents Chemother 44:1878-1886. https://doi.org/10.1128/AAC.44.7.1878-1886.2000
133. Rossolini GM, Condemi MA, Pantanella F, Docquier J-D, Amicosante G, Thaller MC. 2001. Metallo-β-lactamase producers in environmental microbiota: new molecular class B enzyme in Janthinobacterium lividum. Antimicrob Agents Chemother 45:837-844. https://doi.org/10.1128/AAC.45.3.837-844.2001
134. Simm AM, Higgins CS, Pullan ST, Avison MB, Niumsup P, Erdozain O, Bennett PM, Walsh TR. 2001. A novel metallo-β-lactamase, Mbl1b, produced by the environmental bacterium Caulobacter crescentus 1. FEBS Lett 509:350-354. https://doi.org/10.1016/S0014-5793(01)03152-0
135. Docquier J-D, Pantanella F, Giuliani F, Thaller MC, Amicosante G, Galleni M, Frère J-M, Bush K, Rossolini GM. 2002. CAU-1, a subclass B3 metallo-β-lactamase of low substrate affinity encoded by an ortholog present in the Caulobacter crescentus chromosome. Antimicrob Agents Chemother 46:1823-1830. https://doi.org/10.1128/ AAC.46.6.1823-1830.2002
136. Stoczko M, Frère J-M, Rossolini GM, Docquier J-D. 2006. Postgenomic scan of metallo-β-lactamase homologues in rhizobacteria: identification and characterization of BJP-1, a subclass B3 ortholog from Bradyrhizobium japonicum. Antimicrob Agents Chemother 50:1973-1981. https://doi.org/10.1128/AAC.01551-05
137. Leiros H-KS, Borra PS, Brandsdal BO, Edvardsen KSW, Spencer J, Walsh TR, Samuelsen Ø. 2012. Crystal structure of the mobile metallo-β-lactamase AIM-1 from Pseudomonas aeruginosa: insights into antibiotic binding and the role of Gln157. Antimicrob Agents Chemother 56:4341-4353. https://doi.org/10.1128/AAC.00448-12
138. Yong D, Toleman MA, Bell J, Ritchie B, Pratt R, Ryley H, Walsh TR. 2012. Genetic and biochemical characterization of an acquired subgroup B3 metallo-β-lactamase gene, blaAIM-1, and its unique genetic context in Pseudomonas aeruginosa from Australia. Antimicrob Agents Chemother 56:6154-6159. https://doi.org/10.1128/AAC.05654-11
139. Stoczko M, Frère J-M, Rossolini GM, Docquier J-D. 2008. Functional diversity among metallo-β-lactamases: characterization of the CAR-1 enzyme of Erwinia carotovora. Antimicrob Agents Chemother 52: 2473-2479. https://doi.org/10.1128/AAC.01062-07
140. Thaller MC, Borgianni L, Di Lallo G, Chong Y, Lee K, Dajcs J, Stroman D, Rossolini GM. 2011. Metallo-β-lactamase production by Pseudomonas otitidis: a species-related trait. Antimicrob Agents Chemother 55: 118-123. https://doi.org/10.1128/AAC.01062-10
141. Borgianni L, De Luca F, Thaller MC, Chong Y, Rossolini GM, Docquier J-D. 2015. Biochemical characterization of the POM-1 metallo-β-lactamase from Pseudomonas otitidis. Antimicrob Agents Chemother 59:1755-1758. https://doi.org/10.1128/AAC.03843-14
142. Suzuki M, Suzuki S, Matsui M, Hiraki Y, Kawano F, Shibayama K. 2014. A subclass B3 metallo-β-lactamase found in Pseudomonas alcaligenes. J Antimicrob Chemother 69:1430-1432. https://doi.org/10.1093/jac/dkt498
143. Gudeta DD, Pollini S, Docquier J-D, Bortolaia V, Rossolini GM, Guardabassi L. 2016. Biochemical characterization of CPS-1, a subclass B3 metallo-β-lactamase from a Chryseobacterium piscium soil isolate. Antimicrob Agents Chemother 60:1869-1873. https://doi.org/10.1128/ AAC.01924-15
144. Salimraj R, Zhang L, Hinchliffe P, Wellington EMH, Brem J, Schofield CJ, Gaze WH, Spencer J. 2016. Structural and biochemical characterization of Rm3, a subclass B3 metallo-β-lactamase identified from a functional metagenomic study. Antimicrob Agents Chemother 60:5828-5840. https://doi.org/10.1128/AAC.00750-16
145. Allen HK, Moe LA, Rodbumrer J, Gaarder A, Handelsman J. 2009. Functional metagenomics reveals diverse β-lactamases in a remote Alaskan soil. ISME J 3:243-251. https://doi.org/10.1038/ismej.2008.86
146. Wachino J, Yoshida H, Yamane K, Suzuki S, Matsui M, Yamagishi T, Tsutsui A, Konda T, Shibayama K, Arakawa Y. 2011. SMB-1, a novel subclass B3 metallo-β-lactamase, associated with ISCR1 and a class 1 integron, from a carbapenem-resistant Serratia marcescens clinical isolate. Antimicrob Agents Chemother 55:5143-5149. https://doi.org/10.1128/AAC.05045-11
147. Girlich D, Poirel L, Nordmann P. 2012. Diversity of naturally occurring Ambler class B metallo-β-lactamases in Erythrobacter spp. J Antimicrob Chemother 67:2661-2664. https://doi.org/10.1093/jac/dks289
148. Calver AD, Walsh NS, Quinn PF, Baran C, Lonergan V, Singh KP, Orzolek WS. 1997. Dosing of amoxicillin/clavulanate given every 12 hours is as effective as dosing every 8 hours for treatment of lower respiratory tract infection. Lower Respiratory Tract Infection Collaborative Study Group. Clin Infect Dis 024:570-574
149. McKinnon PS, Neuhauser MM. 1999. Efficacy and cost of ampicillinsulbactam and ticarcillin-clavulanate in the treatment of hospitalized patients with bacterial infections. Pharmacother J Hum Pharmacol Drug Ther 19:724-733. https://doi.org/10.1592/phco.19.9.724.31537
150. Li J, Lu Y, Hou J, Chen Y, Miao J, Jia Y, Hou J, Zhang X, Chen D, Hu W. 1997 Sulbactam/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial. Clin Infect Dis 24:498-505. https://doi.org/10.1093/ clinids/24.3.498
151. Sanders WE, Jr, Sanders CC. 1996. Piperacillin/tazobactam: a critical review of the evolving clinical literature. Clin Infect Dis 22:107-123. https://doi.org/10.1093/clinids/22.1.107
152. Sorbera M, Chung E, Ho CW, Marzella N. 2014. Ceftolozane/tazobactam: a new option in the treatment of complicated Gram-negative infections. Pharm Ther 39:825
153. Mazuski JE, Gasink LB, Armstrong J, Broadhurst H, Stone GG, Rank D, Llorens L, Newell P, Pachl J. 2016. Efficacy and safety of ceftazidimeavibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, phase 3 program. Clin Infect Dis 62:1380-1389. https://doi.org/10.1093/cid/ciw133
154. Wiskirchen DE, Crandon JL, Furtado GH, Williams G, Nicolau DP. 2011. In vivo efficacy of a human-simulated regimen of ceftaroline combined with NXL104 against extended-spectrum-β-lactamase (ESBL)-producing and non-ESBL-producing Enterobacteriaceae. Antimicrob Agents Chemother 55:3220-3225. https://doi.org/10.1128/AAC.00024-11
155. Biedenbach DJ, Kazmierczak K, Bouchillon SK, Sahm DF, Bradford PA. 2015 In vitro activity of aztreonam-avibactam against a global collection of Gram-negative pathogens from 2012-2013. Antimicrob Agents Chemother 59:4239-4248. https://doi.org/10.1128/AAC.00206-15
156. Hirsch EB, Ledesma KR, Chang K-T, Schwartz MS, Motyl MR, Tam VH. 2012 In vitro activity of MK-7655, a novel β-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gramnegative bacteria. Antimicrob Agents Chemother 56:3753-3757. https://doi.org/10.1128/AAC.05927-11
157. Lapuebla A, Abdallah M, Olafisoye O, Cortes C, Urban C, Quale J, Landman D. 2015. Activity of meropenem combined with RPX7009, a novel β-lactamase inhibitor, against Gram-negative clinical isolates in New York City. Antimicrob Agents Chemother 59:4856-4860. https:// doi.org/10.1128/AAC.00843-15
158. Wenzler E, Gotfried MH, Loutit JS, Durso S, Griffith DC, Dudley MN, Rodvold KA. 2015. Meropenem-RPX7009 concentrations in plasma, epithelial lining fluid, and alveolar macrophages of healthy adult subjects. Antimicrob Agents Chemother 59:7232-7239. https://doi.org/10.1128/AAC.01713-15
159. Goldstein EJC, Citron DM, Tyrrell KL, Merriam CV. 2013. In vitro activity of biapenem plus RPX7009, a carbapenem combined with a serine β-lactamase inhibitor against anaerobic bacteria. Antimicrob Agents Chemother 57:2620-2630. https://doi.org/10.1128/AAC.02418-12
160. Durand-Réville TF, Guler S, Comita-Prevoir J, Chen B, Bifulco N, Huynh H, Lahiri S, Shapiro AB, McLeod SM, Carter NM. 2017. ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drugresistant Gram-negative bacteria including Acinetobacter baumannii. Nat Microbiol 2:17104. https://doi.org/10.1038/nmicrobiol.2017.104
161. Sader HS, Castanheira M, Huband M, Jones RN, Flamm RK. 2017. WCK 5222 (cefepime-zidebactam) antimicrobial activity tested against clinical isolates of Gram-negative bacteria collected worldwide (2015). Antimicrob Agents Chemother 61:1373-1385. https://doi.org/10.1128/ AAC.00072-17
162. Toney JH, Hammond GG, Fitzgerald PMD, Sharma N, Balkovec JM, Rouen GP, Olson SH, Hammond ML, Greenlee ML, Gao Y-D. 2001. Succinic acids as potent inhibitors of plasmid-borne IMP-1 metallo-β-lactamase. J Biol Chem 276:31913-31918. https://doi.org/10.1074/jbc.M104742200
163. Moloughney JG, Thomas DJ, Toney JH. 2005. Novel IMP-1 metallo-β-lactamase inhibitors can reverse meropenem resistance in Escherichia coli expressing IMP-1. FEMS Microbiol Lett 243:65-71. https://doi.org/10.1016/j.femsle.2004.11.042
164. Olsen L, Jost S, Adolph H-W, Pettersson I, Hemmingsen L, Jørgensen FS. 2006 New leads of metallo-β-lactamase inhibitors from structurebased pharmacophore design. Bioorg Med Chem 14:2627-2635. https://doi.org/10.1016/j.bmc.2005.11.046
165. Hiraiwa Y, Morinaka A, Fukushima T, Kudo T. 2009. metallo-β-lactamase inhibitory activity of phthalic acid derivatives. Bioorg Med Chem Lett 19:5162-5165. https://doi.org/10.1016/j.bmcl.2009.07.018
166. Dmitrienko GI, Viswanatha T, Johnson JW, Ramadhar TR. September 2009 Inhibitors of class B and class D β-lactamases. Patent WO 2009/ 114921 A1
167. Faridoon, Hussein WM, Vella P, Islam NU, Ollis DL, Schenk G, McGeary RP. 2012. 3-Mercapto-1,2,4-triazoles and N-acylated thiosemicarbazides as metallo-β-lactamase inhibitors. Bioorg Med Chem Lett 22:380-386. https://doi.org/10.1016/j.bmcl.2011.10.116
168. Feng L, Yang K-W, Zhou L-S, Xiao J-M, Yang X, Zhai L, Zhang Y-L, Crowder MW. 2012. N-heterocyclic dicarboxylic acids: broad-spectrum inhibitors of metallo-β-lactamases with co-antibacterial effect against antibiotic-resistant bacteria. Bioorg Med Chem Lett 22:5185-5189. https://doi.org/10.1016/j.bmcl.2012.06.074
169. Toney JH, Cleary KA, Hammond GG, Yuan X, May WJ, Hutchins SM, Ashton WT, Vanderwall DE. 1999. Structure-activity relationships of biphenyl tetrazoles as metallo-β-lactamase inhibitors. Bioorg Med Chem Lett 9:2741-2746. https://doi.org/10.1016/S0960-894X(99)00458-8
170. Lienard BMR, Horsfall LE, Galleni M, Frère J-M, Schofield CJ. 2007. Inhibitors of the FEZ-1 metallo-β-lactamase. Bioorg Med Chem Lett 17:964-968. https://doi.org/10.1016/j.bmcl.2006.11.053
171. Gilpin ML, Fulston M, Payne D, Cramp R, Hood I. 1995. Isolation and structure determination of two novel phenazines from a Streptomyces with inhibitory activity against metallo-enzymes, including metallo-β-lactamase. J Antibiot (Tokyo) 48:1081-1085. https://doi.org/10.7164/ antibiotics.48.1081
172. Walter MW, Felici A, Galleni M, Soto RP, Adlington RM, Baldwin JE, Frère J-M, Gololobov M, Schofield CJ. 1996. Trifluoromethyl alcohol and ketone inhibitors of metallo-β-lactamases. Bioorg Med Chem Lett 6:2455-2458. https://doi.org/10.1016/0960-894X(96)00453-2
173. Tsang WY, Dhanda A, Schofield CJ, Page MI. 2004. Kinetics and mechanisms of hydrolysis and aminolysis of thioxocephalosporins. J Org Chem 69:339-344. https://doi.org/10.1021/jo035471t
174. Thomas PW, Cammarata M, Brodbelt JS, Fast W. 2014. Covalent inhibition of New Delhi metallo-β-lactamase-1 (NDM-1) by cefaclor. Chembiochem 15:2541-2548. https://doi.org/10.1002/cbic.201402268
175. Zervosen A, Valladares MH, Devreese B, Prosperi-Meys C, Adolph H, Mercuri PS, Vanhove M, Amicosante G, Van Beeumen J, Frère J. 2001. Inactivation of Aeromonas hydrophila metallo-β-lactamase by cephamycins and moxalactam. FEBS J 268:3840-3850
176. Sanschagrin F, Levesque RC. 2005. A specific peptide inhibitor of the class B metallo-beta-lactamase L-1 from Stenotrophomonas maltophilia identified using phage display. J Antimicrob Chemother 55: 252-255. https://doi.org/10.1093/jac/dkh550
177. Sun Q, Law A, Crowder MW, Geysen HM. 2006. Homo-cysteinyl peptide inhibitors of the L1 metallo-beta-lactamase, and SAR as determined by combinatorial library synthesis. Bioorg Med Chem Lett 16:5169-5175. https://doi.org/10.1016/j.bmcl.2006.07.001
178. Minond D, Saldanha SA, Subramaniam P, Spaargaren M, Spicer T, Fotsing JR, Weide T, Fokin VV, Sharpless KB, Galleni M, Bebrone C, Lassaux P, Hodder P. 2009. Inhibitors of VIM-2 by screening pharmacologically active and click-chemistry compound libraries. Bioorg Med Chem 17:5027-5037. https://doi.org/10.1016/j.bmc.2009.05.070
179. Weide T, Saldanha SA, Minond D, Spicer TP, Fotsing JR, Spaargaren M, Frère JM, Bebrone C, Sharpless KB, Hodder PS, Fokin VV. 2010. NH-1,2,3-triazole inhibitors of the VIM-2 metallo-beta-lactamase. ACS Med Chem Lett 1:150-154. https://doi.org/10.1021/ml900022q
180. Vella P, Hussein WM, Leung EWW, Clayton D, Ollis DL, Mitić N, Schenk G, McGeary RP. 2011. The identification of new metallo-beta-lactamase inhibitor leads from fragment-based screening. Bioorg Med Chem Lett 21:3282-3285. https://doi.org/10.1016/j.bmcl.2011.04.027
181. Kim SK, Sims CL, Wozniak SE, Drude SH, Whitson D, Shaw RW. 2009. Antibiotic resistance in bacteria: novel metalloenzyme inhibitors. Chem Biol Drug Des 74:343-348. https://doi.org/10.1111/j.1747-0285.2009.00879.x
182. Ouyang X, Chang Y-N, Yang K-W, Wang W-M, Bai J-J, Wang J-W, Zhang Y, Wang S-Y, Xie B-B, Wang L. 2017. DNA nanoribbon as a potent inhibitor of metallo-β-lactamases. Chem Commun (Camb) 53: 8878-8881. https://doi.org/10.1039/C7CC04483F
183. Simm AM, Loveridge EJ, Crosby J, Avison MB, Walsh TR, Bennett PM. 2005. Bulgecin A: a novel inhibitor of binuclear metallo-beta-lactamases. Biochem J 387:585-590. https://doi.org/10.1042/BJ20041542
184. Siemann S, Evanoff DP, Marrone L, Clarke AJ, Viswanatha T, Dmitrienko GI. 2002. N-arylsulfonyl hydrazones as inhibitors of IMP-1 metallo-β-lactamase. Antimicrob Agents Chemother 46:2450-2457. https://doi.org/10.1128/AAC.46.8.2450-2457.2002
185. Koteva K, King AM, Capretta A, Wright GD. 2016. Total synthesis and activity of the metallo-β-lactamase inhibitor aspergillomarasmine A. Angew Chem 128:2250-2252. https://doi.org/10.1002/ange.201510057
186. Hammond GG, Huber JL, Greenlee ML, Laub JB, Young K, Silver LL, Balkovec JM, Pryor KD, Wu JK, Leiting B, Pompliano DL, Toney JH. 1999. Inhibition of IMP-1 metallo-β-lactamase and sensitization of IMP-1-producing bacteria by thioester derivatives. FEMS Microbiol Lett 179: 289-296
187. Klingler F-M, Wichelhaus TA, Frank D, Cuesta-Bernal J, El-Delik J, Müller HF, Sjuts H, Göttig S, Koenigs A, Pos KM. 2015. Approved drugs containing thiols as inhibitors of metallo-β-lactamases: strategy to combat multidrug-resistant bacteria. J Med Chem 58:3626-3630. https://doi.org/10.1021/jm501844d
188. Kurosaki H, Yamaguchi Y, Higashi T, Soga K, Matsueda S, Yumoto H, Misumi S, Yamagata Y, Arakawa Y, Goto M. 2005. Irreversible Inhibition of metallo-β-lactamase (IMP-1) by 3-(3-mercaptopropionylsulfanyl) propionic acid pentafluorophenyl ester. Angew Chem Int Ed Engl 44:3861-3864. https://doi.org/10.1002/anie.200500835
189. Payne DJ, Bateson JH, Gasson BC, Khushi T, Proctor D, Pearson SC, Reid R. 1997. Inhibition of metallo-β-lactamases by a series of thiol ester derivatives of mercaptophenylacetic acid. FEMS Microbiol Lett 157: 171-175. https://doi.org/10.1111/j.1574-6968.1997.tb12769.x
190. Concha NO, Janson CA, Rowling P, Pearson S, Cheever CA, Clarke BP, Lewis C, Galleni M, Frere J-M, Payne DJ. 2000. Crystal structure of the IMP-1 metallo β-lactamase from Pseudomonas aeruginosa and its complex with a mercaptocarboxylate inhibitor: binding determinants of a potent, broad-spectrum inhibitor. Biochemistry 39:4288-4298. https:// doi.org/10.1021/bi992569m
191. Lassaux P, Hamel M, Gulea M, Delbrück H, Mercuri PS, Horsfall L, Dehareng D, Kupper M, Frere J-M, Hoffmann K. 2010. Mercaptophosphonate compounds as broad-spectrum inhibitors of the metallo-β-lactamases. J Med Chem 53:4862-4876. https://doi.org/10.1021/ jm100213c
192. García-Sáez I, Hopkins J, Papamicael C, Franceschini N, Amicosante G, Rossolinill GM, Galleni M, Frère JM, Dideberg O. 2003. The 1.5-Å structure of Chryseobacterium meningosepticum zinc β-lactamase in complex with the inhibitor, D-captopril. J Biol Chem 278:23868-23873. https://doi.org/10.1074/jbc.M301062200
193. King DT, Worrall LJ, Gruninger R, Strynadka NCJ. 2012. New Delhi metallo-β-lactamase: structural insights into β-lactam recognition and inhibition. J Am Chem Soc 134:11362-11365. https://doi.org/10.1021/ ja303579d
194. Damblon C, Jensen M, Ababou A, Barsukov I, Papamicael C, Schofield CJ, Olsen L, Bauer R, Roberts GCK. 2003. The inhibitor thiomandelic acid binds to both metal ions in metallo-β-lactamase and induces positive cooperativity in metal binding. J Biol Chem 278:29240-29251. https:// doi.org/10.1074/jbc.M301562200
195. Siemann S, Clarke AJ, Viswanatha T, Dmitrienko GI. 2003. Thiols as classical and slow-binding inhibitors of IMP-1 and other binuclear metallo-β-lactamases. Biochemistry 42:1673-1683. https://doi.org/10.1021/bi027072i
196. Kurosaki H, Yamaguchi Y, Yasuzawa H, Jin W, Yamagata Y, Arakawa Y. 2006 Probing, inhibition, and crystallographic characterization of metallo-beta-lactamase (IMP-1) with fluorescent agents containing dansyl and thiol groups. ChemMedChem 1:969-972. https://doi.org/10.1002/cmdc.200600115
197. Hinchliffe P, González MM, Mojica MF, González JM, Castillo V, Saiz C, Kosmopoulou M, Tooke CL, Llarrull LI, Mahler G. 2016. Cross-class metallo-β-lactamase inhibition by bisthiazolidines reveals multiple binding modes. Proc Natl Acad Sci U S A 113:E3745-E3754. https://doi.org/10.1073/pnas.1601368113
198. Whelan S, Goldman N. 2001. A general empirical model of protein evolution derived from multiple protein families using a maximumlikelihood approach. Mol Biol Evol 18:691-699